Utama › Artritis Reumatoid › New York
Kajian klinikal Artritis Reumatoid di New York
15 kajian untuk Artritis Reumatoid sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
RA-PRO PRAGMATIC TRIAL
- New York University, New York
- Hospital for Special Surgery, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- dan 1 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Local Institution - 0081, New York
- Local Institution - 0079, New York
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Northwell Health Physician Partners Rheumatology At Great Neck /ID# 275621, Great Neck
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Equity Medical, The Bronx
- Equity Medical, The Bronx
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07137598Exactech Shoulder Post Market Clinical Follow-up Study
- Hospital for Joint Diseases - NYU Langone Health, New York
- Lenox Health Greenwich Village, New York
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05603728A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06570798A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
Mengambil pesertaFasa 1/2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06733935A Study of AZD0120 in Autoimmune Diseases
- Research Site, New York
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07295847Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2026 · NCT07138898Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
- University of Rochester, Rochester
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT05197530Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
- Hospital for Special Surgery, New York
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT05782335Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
- Weill Cornell Medical College, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jan 2026 · NCT07222696Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
- St. Lawrence Health, Potsdam
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jun 2025 · NCT07034196ConsideRAte Study - Splenic Stimulation for RA
- NYU Langone, Brooklyn
Mengambil peserta
Umur 22 hingga 75 · Semua jantina · Dikemas kini 22 Mei 2024 · NCT05003310Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.